Translation of DELOS nanovesicles formulations into new pharmaceutical candidates

Lídia Ballell, from the Nanomol-Bio Group, ICMAB-CSIC

Date: Friday, 22 July 2022
Time: 11:00 am
Venue: Sala de Graus (C1/070-1) - Universtitat Autònoma de Barcelona and Online. Register here to attend by Zoom.

Abstract:

DELOS nanovesicles, scientifically known as Quatsomes, are thermodynamically stable nanoscopic unilamellar vesicles with remarkable physicochemical characteristics, in terms of homogeneity, morphology, particle size, and stability. Knowing all the potentiality that these nanocarriers can present for drug delivery, this Industrial Thesis is devoted to study the translation of DELOS nanovesicles into new pharmaceutical products to obtain nanomedicines in more advanced formulation states by ensuring compliance with the quality, regulatory and finished product standards required by the pharmaceutical industry. In summary, the results achieved in this Thesis support that DELOS nanovesicles can be successfully used as promising pharmaceutical products for drug delivery.

Supervisors:

• Nora Ventosa, ICMAB-CSIC
• Lídia Ferrer, Nanomol Technologies, SL

PhD Comittee:

• President: Maria Pilar Vinardell Martinez Hidalgo, University of Barcelona, Spain
• Secretary: Imma Ratera, ICMAB-CISC, Spain
• Vocal: Fiorenza Rancan, Charité – Universitätsmedizin Berlin, Germany

University: Universitat Autònoma de Barcelona (UAB)
PhD Programme: PhD Programme in Materials Science

Register here to attend online by Zoom.